EUVIMEDDescoperă EUVIMED
Crossref

Daphnetin Alleviates Liver Fibrosis by Inducing Ferritinophagy‐Mediated Ferroptosis in Activated Hepatic Stellate Cells

Laiyu Zhu, You Wu, Sainan Chang, Xinxin Ci iD

Phytotherapy Research · 2026-02 · 40 (2) · 473-487

DOI: 10.1002/ptr.70134 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2025-12-05. Written by Laiyu Zhu and 3 co-authors. Institution: Institute of Liver Diseases, The First Hospital of Jilin University, Changchun, China. Major MEDLINE topics: Hepatic Stellate Cells, Ferroptosis, Umbelliferones, Liver Cirrhosis. Cited 5 times so far (Crossref); 42 references. Funded by: Natural Science Foundation of Jilin Province, National Natural Science Foundation of China.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Liver fibrosis is an increasingly serious global health issue, and an effective treatment strategy is to inhibit the activation of hepatic stellate cells (HSCs). The role of daphnetin (Daph), which is a natural coumarin derivative isolated from plants of the genus Daphne, in the treatment of hepatic fibrosis is still unclear. Mice were treated with carbon tetrachloride (CCl 4 ), and the inhibitory effect of Daph on hepatic fibrosis was evaluated. In vitro, the effect of Daph on the activated human HSCs line LX‐2 was studied. In vivo, Daph alleviated collagen accumulation and reduced the expression of fibrotic genes. However, these changes were reversed with ferrostatin‐1 (Fer‐1). In vitro, Daph induced ferroptosis in LX‐2 cells, which was characterized by increased lipid peroxidation and iron accumulation. However, deferoxamine (DFO) and Fer‐1 partially abrogated the antifibrotic effect of Daph. Mechanically, Daph exerted an antifibrotic effect by ubiquitinating glutathione peroxidase 4 (GPX4) and stimulating ferritinophagy‐mediated ferroptosis in HSCs. These results indicated that Daph promoted the ubiquitination of GPX4 and ferritinophagy‐mediated ferroptosis in HSCs, which could provide new clues for further pharmacological research on the antifibrotic effect of Daph.

Subjects

MeSH terms (MEDLINE)

Hepatic Stellate CellsFerroptosisUmbelliferonesLiver CirrhosisFerritinsAnimalsHumansMiceMaleCell LineCarbon TetrachlorideMice, Inbred C57BLLipid PeroxidationAutophagyPhospholipid Hydroperoxide Glutathione PeroxidaseCyclohexylaminesPhenylenediamines

Author keywords

GPX4daphnetinferroptosisliver fibrosis

Substances

UmbelliferonesdaphnetinFerritinsCarbon TetrachloridePhospholipid Hydroperoxide Glutathione Peroxidaseferrostatin-1CyclohexylaminesPhenylenediamines

Authors and institutions

  • Institute of Liver Diseases, The First Hospital of Jilin University, Changchun, China.
  • Jilin Provincial Key Laboratory of Women's Reproductive Health, The First Hospital of Jilin University, Changchun, Jilin, China.
  • Central Sterile Supply Department, The First Hospital of Jilin University, Changhun, Jilin, China.

ORCID profiles: Xinxin Ci

Funding

  • Natural Science Foundation of Jilin Province
  • National Natural Science Foundation of China

Cite

APA

Zhu, L., Wu, Y., Chang, S., & Ci, X. (2026). Daphnetin Alleviates Liver Fibrosis by Inducing Ferritinophagy‐Mediated Ferroptosis in Activated Hepatic Stellate Cells. Phytotherapy Research, 40(2), 473-487. https://doi.org/10.1002/ptr.70134

Vancouver

Zhu L, Wu Y, Chang S, Ci X. Daphnetin Alleviates Liver Fibrosis by Inducing Ferritinophagy‐Mediated Ferroptosis in Activated Hepatic Stellate Cells. Phytotherapy Research. 2026;40(2):473-487. doi:10.1002/ptr.70134

BibTeX
@article{Zhu2026,
  author = {Zhu, Laiyu and Wu, You and Chang, Sainan and Ci, Xinxin},
  title = {Daphnetin Alleviates Liver Fibrosis by Inducing Ferritinophagy‐Mediated Ferroptosis in Activated Hepatic Stellate Cells},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {2},
  pages = {473--487},
  doi = {10.1002/ptr.70134}
}
Start for free →